Article Sidebar

PDF
Date Published: 15/12/2023
Abstract Views: 486
Views PDF: 236
DOI: https://doi.org/10.59873/vjid.v4i44.329
Issue
Vol. 4 No. 44 (2023): Vietnam Journal of Infectious Diseases
Section
Scientific research
How to Cite
Tran, L. T., Le, T. T. T., & Pham, N. T. (2023). CLINICAL AND TYPICAL IMAGING CHARACTERISTICS OF CRYPTOCOCCAL MENINGITIS IN HIV INFECTED PATIENT: A CASE REPORT. Vietnam Journal of Infectious Diseases, 4(44), 45-48. https://doi.org/10.59873/vjid.v4i44.329

CLINICAL AND TYPICAL IMAGING CHARACTERISTICS OF CRYPTOCOCCAL MENINGITIS IN HIV INFECTED PATIENT: A CASE REPORT

Le Thang Tran1,, Thi Thanh Thuy Le1, Ngoc Thach Pham1
1 National Hospital for Tropical Diseases

Main Article Content

Abstract

Although Cryptococcal infection is worldwide distribution, it is more seen in the immunocompromised patients. Cryptococcus neoformans is the most common central neurvous system fungal pathogen in HIV infected patients. Besides clinical features and laboratory tests, imaging findings play an important role in the evaluation of cryptococcal infection. In this paper we present an immunocompromised HIV infected case of C. neoformans meningitis with clinical features and imaging characteristics by MR image.

Article Details

Keywords

C. neoformans, Cryptococcus neoformans, Virchow Robin spaces, diffusion weighted imaging, apparent diffusion coefficient, fluid attenuate inversion

References

1. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.WHO.March 2018.
2. Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol 2017;13:13-24.
3. Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ. The primary target organ of cryptococcus gattii is different from that of cryptococcus neoformans in a murine model. Mbio 2012;3(3):1917-8.
4. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010; (50):291-322.
5. Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, Ho CM, et al. Differentpresentations and outcomes between hiv-infected and hiv-uninfected patients with cryptococcal meningitis. J Microbiol Immunol Infect 2012;45:296-304.
6. Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, Denning DW, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis 2022 Aug 29.
7. Katchanov J, Branding G, Jefferys L, Arasteh K, Stocker H, Siebert E. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution. Int J STD AIDS 2016;27(2).
8. Loyse A, Moodley A, Rich P, Molloy SF, Bicanic T, Bishop L, et al.Neurological, visual, and MRI brain scan findings in 87 south african patients with HIV-associated cryptococcal
meningoencephalitis. J Infect 2014;70(6):668-75.
9. Ruiz A, Post MJ, Bundschu CC. Dentate nuclei involvement in AIDS patients with CNS cryptococcosis: imaging findings with pathologic correlation. J Comput Assist Tomogr 1997;21(2):175-82.
10. Jain KK, Mittal SK, Kumar S, Gupta RK. Imaging features of central nervous system fungal infections. Neurol India 2007;55(3):241-50.